Jan Philipp Schmid

[Jeremias Lab @Jeremias_lab]

📢New paper alert: Our paper "Combined proteomics and CRISPR‒Cas9 screens in PDX identify ADAM10 as essential for leukemia in vivo" has now been published in Molecular Cancer https://t.co/PnD7wJD0fR

[Jeremias Lab @Jeremias_lab]

Last month we went hiking in the bavarian alps. We had a wonderful lab trip with nice weather and delicious food at a hut. ⛰️☀️

[Jeremias Lab @Jeremias_lab]

🚨#postdocposition
We are looking for a motivated #postdoc with experiences in molecular biology including CRISPR-Cas9 technology / flow cytometry / mouse models / "omics" technologies with data analysis. Please RT.
Check out the details here👇
https://t.co/TRvj43T35y

[Jeremias Lab @Jeremias_lab]

📢 Meet us today at #EACR2022 !
You can find @jp_schmid during the Poster in the Spotlight Session and @katharinahunt at P363.
Tomorrow Irmela Jeremias will talk about " Moving out of the niche home – A risky decision" Auditorium 1 - 16:10 @EACRnews

[Jeremias Lab @Jeremias_lab]

📢 Another talk from our lab will be "The sheddase domain of ADAM10 augments the interaction of leukemia cells with the bone marrow niche in vivo as shown by reconstituting PDX leukemia cells with CRISPR-CAS9-induced knockout" by @jp_schmid Hall Strauss 3 17:15 CEST

[Jeremias Lab @Jeremias_lab]

Meet us at #EHA2022!
On Saturday Irmela Jeremias will be part of the session "from biology to preclinical models in ALL" in Hall Lehar 3-4.
@jp_schmid will present his data during the session "biology of leukemic transformation" in Hall Strauss 3.
See you there! @EHA_Hematology